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Madison, WisconsinABSTRACT Islet amyloid polypeptide (IAPP or Amylin) is a 37-residue, C-terminally amidated pancreatic hormone, cose-
creted with insulin that forms islet amyloid in type 2 diabetes. Islet amyloid formation is complex and characterizing preamyloid
oligomers is an important topic because oligomeric intermediates are postulated to be the most toxic species produced during
fibril formation. A range of competing models for early oligomers have been proposed. The role of the amidated C-terminus in
amyloid formation by IAPP and in stabilizing oligomers is not known. Studies with unamidated IAPP have provided evidence for
formation of an antiparallel dimer at pH 5.5, stabilized by stacking of His-18 and Tyr-37, but it is not known if this interaction is
formed in the physiological form of the peptide. Analysis of a set of variants with a free and with an amidated C-terminus shows
that disrupting the putative His-Tyr interaction accelerates amyloid formation, indicating that it is not essential. Amidation to
generate the physiologically relevant form of IAPP accelerates amyloid formation, demonstrating that the advantages conferred
by C-terminal amidation outweigh increased amyloidogenicity. The analysis of this variant argues that IAPP is not under strong
evolutionary pressure to reduce amyloidogenicity. Analysis of an H18Q mutant of IAPP shows that the charge state of the N-
terminus is an important factor controlling the rate of amyloid formation, even though the N-terminal region of IAPP is believed
to be flexible in the amyloid fibers.INTRODUCTIONMore than 30 different human diseases involve the deposi-
tion of partially ordered protein aggregates known as
amyloids (1–3). Although there is no sequence similarity
between the proteins involved, all amyloid deposits are
rich in b-sheet structure and they share several common
features including the ability to bind extrinsic fluorescent
dyes such as thioflavin-T (ThT) (4). Islet amyloid polypep-
tide (IAPP, or amylin), a pancreatic hormone cosecreted
with insulin, forms islet amyloid in type 2 diabetes, and
leads to b-cell dysfunction and cell death (5–13). Formation
of islet amyloid is also believed to contribute significantly to
the failure of islet cell transplants (14–16). Islet amyloid
formation is complex and not well understood, despite its
importance.
The polypeptide is 37 residues in length, contains a disul-
fide bond between residues 2 and 7, and has an amidated
C-terminus, which is required for full biological activity
(Fig. 1 A) (17). IAPP is considered to be natively unfolded
in its monomeric state, but is one of the most amyloidogenic
natural sequences known. A key issue in the field is the
characterization of preamyloid oligomers. The role of the
C-terminus in amyloid formation is relatively unexplored,
but recent solution NMR studies using recombinant human
IAPP (hIAPP) strongly suggested that His-18 and Tyr-37
make early contacts during amyloid formation by an unami-
dated variant of IAPP at acidic pH (18). His-aromatic aminoSubmitted November 6, 2013, and accepted for publication December 27,
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0006-3495/14/04/1520/8 $2.00acid interactions are known to be important in globular
proteins (19), but have not been widely considered in the
context of amyloid formation, and it is not known if these in-
teractions are formed in the naturally occurring amidated
form of IAPP or whether they are important if present. A
model of an antiparallel stable dimer generated by stacking
of the side chains of His-18 and Tyr-37 was proposed based
on the NMR studies (18). However, removal of the charged
carboxylate and replacement with a neutral amide group to
generate the physiological form of IAPP could alter inter-
actions with the His side chain. In addition, the interactions
involvingHis-18 and a charged C-terminus should beweaker
at physiological pH because the pKa of His-18 is expected to
be near, or below 7 in the monomeric state. Thus, the fraction
of peptide with a protonated His-18 will decrease as the pH
rises to physiological valves. Along these lines, previous
studies of C-terminus amidated IAPP variants that contain
the fluorescent Tyr/Phe analog 4-cyanophenylalanine argued
that the aromatic side chains remain solvated during the lag
phase and suggested that aromatic-aromatic interactions
involving Tyr-37 or interactions of Tyr-37 with a neutral
His do not develop during the lag time (20). Other models
of low order oligomers have been proposed; including, for
example, the formation of helical intermediates or the gener-
ation of dimers involving a side-by-side arrangement of
b-hairpin monomers (21–25). Thus, the role of potential
His-18-Tyr-37 interactions is not clear, and the role of C-ter-
minus in amyloid formation is not completely defined, nor is
the nature of early structure acquisition clear. These issues
are important because some inhibitors may target early olig-
omeric structures, and because oligomeric intermediates arehttp://dx.doi.org/10.1016/j.bpj.2013.12.052
FIGURE 1 (A) Primary sequence of hIAPP and
the two IAPP variants designed to study the poten-
tial His-18, Tyr-37 interaction in the naturally
occurring amidated background. All peptides
contain a disulfide bridge between residues 2 and
7, and an amidated C-terminus. (B) ThT fluo-
rescence monitored kinetic experiments. Dots,
hIAPP; Squares, H18Q-hIAPP; Triangles, H18L-
hIAPP. All experiments were conducted in
20 mM, pH 7.4 Tris buffer, without stirring at
25C. (C) TEM image of the amyloid fibrils
formed by hIAPP. (D) TEM image of the amyloid
fibrils formed by H18Q-hIAPP. (E) TEM image of
the amyloid fibrils formed by H18L-hIAPP. Scale
bars represent 100 nm.
Analysis of Preamyloid Intermediate 1521thought to be the most toxic species (10,13,26–28). Here, we
investigate the role of the C-terminus of IAPP and its inter-
action with His-18 during amyloid formation by IAPP.MATERIALS AND METHODS
Peptide synthesis and purification
Peptides were synthesized on a 0.1 mmol scale using a CEM Liberty
microwave peptide synthesizer, and 9-fluornylmethoxycarbonyl (Fmoc)
chemistry. Solvents used were ACS-grade. 5-(40-fmoc-aminomethyl-30, 5-
dimethoxyphenol) valeric acid (PAL-PEG-PS) resin was used to form an
amidated C-terminus. Fmoc-L-Tyr (OtBu)-PEG-PS resin was used for the
preparation of peptides with a free C-terminus. Standard Fmoc reaction
cycles were used. Fmoc protected pseudoproline dipeptide derivatives
were incorporated at positions 9–10, 19–20, and 27–28 to facilitate the
synthesis (29). The b-branched residues, Arg, and all pseudoproline dipep-
tide derivatives were double coupled. A maximum temperature of 50Cwas
used for the coupling of His and Cys to reduce the possibility of racemiza-
tion (30). Peptides were cleaved from the resin by standard trifluoroacetic
acid (TFA) methods. Crude peptides were partially dissolved in 20% acetic
acid (v/v), frozen in liquid nitrogen, and lyophilized to increase their
solubility. The dry peptide was redissolved in dimethyl sulfoxide at room
temperature to promote the formation of the disulfide bond (31,32). Pep-
tides were purified by reverse-phase high-performance liquid chromatog-
raphy using a Vydac or Proto 300 C18 preparative column (10 mm 
250 mm). A two buffer gradient was used: buffer A consisted of 100%
H2O and 0.045% HCl (v/v) and buffer B included 80% acetonitrile, 20%
H2O, and 0.045% HCl. HCl was used as the counterion instead of TFAbecause residual TFA can influence amyloid formation. Analytical high-
performance liquid chromatography was used to check the purity of
peptides before use. Matrix-assisted laser desorption/ionization time of
flight mass spectrometry confirmed the correct molecular mass. hIAPP,
expected 3903.3, observed 3902.8; H18Q-hIAPP, expected 3894.3,
observed 3894.4; H18L-hIAPP, expected 3879.3, observed 3879.3; free
CT-hIAPP, expected 3904.2, observed 3903.8; free H18Q CT-IAPP, ex-
pected 3895.3, observed 3895.9.Sample preparation
Peptides were dissolved in 100% hexafluoroisopropanol at a concentration
of 1.6 mM and stored at 20C. For kinetic studies, 8 mL aliquots were
lyophilized and redissolved in 800 mL of 20 mM Tris-HCl buffer, pH 7.4.
For the seeding assays, preformed fibrils were produced from kinetic
studies. The solution was incubated and ThT fluorescence was monitored
to ensure that fibril formation had occurred. Seeds were freshly prepared
to ensure reproducibility.ThT fluorescence assays
For kinetic assays, solutions were prepared by adding 20 mM, pH 7.4 Tris–
HCl buffer containing ThT to lyophilized dry peptides for a final peptide con-
centration of 16 mM. For the seeding assays, preformed fibrils mixed with
Tris-HCl buffered ThT solution were added to the lyophilized dry hIAPP
samples. The final condition was 16 mM peptide, 32 mM ThT, 1.6 mM seeds
(in monomer units), and 20 mM Tris-HCl at pH 7.4. Measurements were
made at 25Cusing aBeckmanCoulterDTX880plate readerwithout stirring.Biophysical Journal 106(7) 1520–1527
1522 Tu et al.Transmission electron microscopy (TEM)
TEMwas performed at the Life Science Microscopy Center at Stony Brook
University. Aliquots were removed from the same solutions that were used
for the fluorescence measurements. 5 mL of peptide solution was placed on
a carbon-coated Formvar 300 mesh copper grid for 1 min and then nega-
tively stained with saturated uranyl acetate for another 1 min.Two-dimensional infrared spectroscopy (2DIR)
Samples for 2DIR were prepared at 0.5 mM in 20 mM pH 7.4 Tris-HCl
buffer in D2O, in a CaF2 infrared cell with a 56 mmTeflon spacer, after over-
night deuterium exchange in 100% hexafluoroisopropanol-d (Aldrich).
2DIR spectra were collected as described previously (33). Briefly, 60 fs
mid-IR pulses centered at 6 mm, generated by optical parametric amplifica-
tion of light from a regeneratively amplified Ti: sapphire laser system, were
split into pump and probe beams, the former of which was sent through a
Ge-based mid-IR acoustooptic pulse shaper to generate the pump pulse
pair needed for 2D spectra and to provide shot-to-shot phase cycling. After
passing through the excitation region of the pump beam, the probe beam
was detected and digitized with a 64 element MCT detector array system
(Infrared Systems). The pump and probe beams were polarized parallel
in all experiments.RESULTS AND DISCUSSION
Design of a model system to study the role of
His-18 and Tyr-37 interactions in IAPP amyloid
formation
The primary sequence of hIAPP is shown in Fig. 1 A. The
molecule contains a single histidine at position 18 and three
aromatic residues, including a single tyrosine at the C-termi-
nus. Several structural models of hIAPP amyloid fibrils have
been proposed; one based on the analysis of small peptide
fragments of hIAPP and two based on solid-state NMR
studies (34,35). His-18 is buried in the core of the fibril in
the model based on crystallographic studies, and in one of
the NMR-based models. However, calculations performed
at the level of the linearized Poisson-Boltzmann equation
argue that the network of interactions formed by His-18 is
enough to overcome the desolvation barrier for a neutral
His side chain (36). The C-terminal Tyr is part of the ordered
b-sheet core in all models and the parallel in register
b-structure mean that the C-terminus of the one polypeptide
chain is close to the C-terminus of its neighbors. Thus, there
should be considerable charge repulsion in amyloid fibrils
formed from variants with a free C-terminus, provided of
course that they adopt the same structure.
To investigate the potential importance of His-18 and
Tyr-37 interactions, we synthesized hIAPP variants in which
His-18 was replaced by the neutral residues, Gln and Leu.
These substitutions were chosen because they are roughly
similar in volume to His. Obviously, they differ in shape
and hydrophobicity and these factors could influence amy-
loid formation. However, the use of two different substitu-
tions at position 18 helps to ensure that any conclusions
are robust. Additional variants were prepared with a freeBiophysical Journal 106(7) 1520–1527C-terminus and substitutions at position-18. (Fig. 1 A and
Fig. 2 A). The rate of amyloid formation was measured
using fluorescent detected ThT binding assays. ThT is a
small dye whose quantum yield is enhanced when it binds
to amyloid fibrils (37). ThT assays accurately report on
IAPP amyloid formation kinetics and the presence of the
dye does not alter the kinetics under the conditions used
here (38).
The data collected for hIAPP show a typical sigmoidal
curve with a lag phase followed by a growth phase and
then a steady state in which soluble peptide is in equilibrium
with amyloid fibrils (Fig. 1 B, dots). The H18Q-hIAPP
single mutant forms amyloid fibrils moderately faster than
hIAPP (Fig. 1 B, squares) and the fibril morphology is
similar to hIAPP fibrils as judged by TEM and 2DIR
(Fig. 1, C and D, and Fig. 3). This argues that any inter-
actions between His-18 and the C-terminus Tyr are not crit-
ical for amyloid formation because their disruption at
physiologically relevant pH does not inhibit amyloid forma-
tion, but actually accelerates it. When His-18 is replaced by
Leu, a less polar substitution than Gln, even more dramatic
effects are observed and amyloid formation is much faster.
No apparent lag phase is observed for H18L-hIAPP
(Fig. 1 B, triangles). The protonated state of His-18 signif-
icantly affects the rate of amyloid formation (39), however
the pH used in these studies is 7.45 0.2, and His-18 is
expected to be largely deprotonated under these conditions.
Hence, the effects are unlikely to be due simply to removal
of a positive charge.IAPP variants with a free C-terminus behave
differently than C-terminal amidated IAPP
Previous work has shown that the natural amidated form of
hIAPP and an IAPP variant with a free acid at its C-terminus
form a different distribution of oligomers during the aggre-
gation process (40), but putative His-18 and Tyr-37 inter-
actions have not been probed.
To examine the possible role of interactions between
His-18 and the C-terminus, we synthesized variants of
hIAPP with a free acid C-terminus (denoted free CT-hIAPP,
Fig. 2 A). This is the same form that was used in the solution
NMR studies that defined the head-to-tail dimers (18). Free
CT-hIAPP formed amyloid much more slowly than hIAPP,
by a factor of 4, as judged by the t50 value of the two kinetic
profiles (Fig. 2 B, dots and squares). The t50 is defined as the
time required for 50% of the signal change in a ThT ex-
periment. TEM images revealed differences in fibril
morphology. hIAPP formed long and dense fibrils, whereas
the free CT-hIAPP fibrils are shorter and curly (Fig. 2, C
and D). We also prepared an hIAPP variant with a free
acid C-terminus and a His-to-Gln substitution (denoted
H18Q free CT-IAPP, Fig. 2 A) to analyze the impact of re-
placing His-18 in the free carboxylate background. H18Q
free CT-IAPP formed amyloid faster than free CT-hIAPP
FIGURE 2 (A) Primary sequence of hIAPP and
the two IAPP variants with a free C-terminus. All
peptides contain a disulfide bridge between resi-
dues 2 and 7. (B) ThT fluorescence monitored
kinetic experiments. Dots, hIAPP; Triangles,
H18Q free CT-IAPP; Squares, free CT-hIAPP.
All experiments were conducted in 20 mM,
pH 7.4 Tris buffer, without stirring at 25C. (C)
TEM image of the amyloid fibrils formed by
hIAPP. The micrograph is the same as the one
shown in Fig. 1. (D) TEM image of the amyloid
fibrils formed by free CT-hIAPP. (E) TEM image
of the amyloid fibrils formed by H18Q free CT-
IAPP. Scale bars represent 100 nm.
Analysis of Preamyloid Intermediate 1523(Fig. 2 B, triangles and squares). Again, the data show that
replacement of His-18 accelerates amyloid formation and
thus indicates that His-18-Tyr-37 interactions are not essen-
tial for amyloid formation in either background at pH 7.4.
We used 2DIR to probe the secondary structure of amy-
loid fibrils formed by the different variants. The IR transi-
tions of the Amide-I0 modes of proteins are sensitive to
secondary structure and 2DIR has been used to monitorFIGURE 3 Two-dimensional infrared spectroscopy confirms that all peptides
Free CT-hIAPP. (E) H18Q free CT-IAPP. The diagonal slices of each spectrumsecondary structure as well as the packing of individual
peptides in IAPP amyloid (41,42). 2DIR spectra were
recorded for all of the samples and are displayed in Fig. 3.
The spectra are broadly similar to previously reported
spectra of hIAPP (42). The slice along the diagonal in the
2DIR contains similar information to a traditional linear
IR spectrum, but with more prominent b-sheet signal
because b-sheets and a-helices have stronger transitionsform amyloid fibrils. (A) hIAPP. (B) H18L-hIAPP. (C) H18Q-hIAPP. (D)
are shown at the bottom of the figure. To see this figure in color, go online.
Biophysical Journal 106(7) 1520–1527
1524 Tu et al.than random coils in 2D IR spectra (43) The diagonal slices
are very similar and all display a prominent, sharp peak
centered near 1617–1620 cm1, a frequency range that
corresponds to b-structure. The data show that all of the
variants form b-sheet-rich aggregates.FIGURE 4 Nonadditive effects were observed between the C-terminus
and His-18. The histogram shows the effect caused by mutation or by
modification of the C-terminus. The expected additive result is indicated
by the arrow.Nonadditive effects are observed with multiple
mutations
hIAPP with a free C-terminus formed amyloid significantly
more slowly than wild-type (WT) hIAPP with a fourfold
longer t50, whereas the His-to-Gln mutation at position 18
slightly accelerated the process (~20%). If the effects of
the changes are independent there should be no synergy
between them and the effect of a double mutation should
be the sum of the individual effects. This approach is widely
used in studies of protein folding and protein stability where
the processes under consideration can usually be described
by simple models using a limited number of thermodynamic
states (44). Amyloid formation is significantly more com-
plex and may involve multiple pathways and heterogeneous
distributions of intermediates. In addition, it is presently
impossible to measure rate constants for each of the micro-
scopic steps in amyloid formation and, instead, t50 or the lag
time is often used as a proxy for the time constant. However,
t50 and the lag time likely cannot be related to the lifetime of
a single kinetic step. These considerations indicate that there
are considerable complications in using a double mutant
cycle type approach to analyze amyloid kinetics, nonethe-
less, a semiquantitative analysis can still provide insight.
If 1/t50 is used as a proxy for the rate, i.e., t50 is used as a
proxy for an individual time constant, then one expects
additive effects on the value of ln(1/t50) if two substitutions
are independent, or equivalently, multiplicative effects on
(1/t50). Here, we used the ratio (t50/t50-WT) where t50-WT is
the t50 of normal amidated WT hIAPP. The expected addi-
tive effect was estimated by multiplying this parameter
(t50 of single mutant/ t50-WT) calculated for the two single
substitutions. The analysis revealed that the observed effects
were not equal to the result expected for noninteracting sites
(Fig. 4). The t50 for H18Q free CT-IAPP is 0.8 that of hIAPP,
whereas the expected result, assuming independent effects,
is 3.2-fold. This analysis suggests that the C-terminal
carboxylate interacts with His-18, but that the interaction
does not favor amyloid formation.FIGURE 5 Amyloid fibrils formed by IAPP variants with a free acid
C-terminus are much less effective at seeding amyloid formation by
hIAPP than amyloid fibrils formed by variants with an amidated C-termi-
nus. ThT fluorescence monitored kinetic experiments: Dots, unseeded
hIAPP; Open circles, hIAPP seeded by hIAPP amyloid fibrils; Diamonds,
hIAPP seeded by H18Q-hIAPP amyloid fibrils; Triangles, hIAPP seeded
by free CT-hIAPP amyloid fibrils; Squares, hIAPP seeded by free H18Q
CT-IAPP amyloid fibrils. Seeds were present at 10% concentration in
monomer units.Amyloid fibrils formed by IAPP variants with a
free acid C-terminus do not seed amyloid
formation by hIAPP
We further examined the structural similarity between
hIAPP fibrils and the fibrils formed by different hIAPP var-
iants using seeding experiments. Preformed hIAPP fibrils
can be used as seeds to seed amyloid formation by mono-
meric hIAPP leading to a bypassing of the lag phase. Seed-Biophysical Journal 106(7) 1520–1527ing is generally specific and structural differences between
different proteins impact seeding efficiencies (45,46).We
first seeded hIAPP with hIAPP fibrils as a control. As
expected, a bypass of the lag phase was observed and a
significant increase in ThT fluorescence in the first few
hours was detected (Fig. 5, open circles). We then tested
the ability of fibrils formed by the different variants to
seed hIAPP. When hIAPP was seeded by preformed
H18Q-hIAPP fibrils, a curve similar to the control study
was observed, suggesting that H18Q- hIAPP formed fibrils
that are very similar to those generated by hIAPP fibrils
(Fig. 5, diamonds). In striking contrast, either of the variants
with a free C-terminus is much less effective at seeding
amyloid formation by hIAPP and a significant lag phase is
still observed. (Fig. 5, squares and triangles). This result
highlights the importance of the C-terminus and strongly
suggests that there are differences in the details of the fibril
Analysis of Preamyloid Intermediate 1525structure formed by amidated and unamidated hIAPP. It
is striking that simply replacing an amide group at the
C-terminus by a carboxylate has more effect than replacing
His-18 by residues that differ significantly in shape and
polarity.Analysis of H18Q-hIAPP reveals that the
protonation state of the N-terminus affects the
rate of amyloid formation
The rate of hIAPP amyloid formation is pH dependent and is
faster above pH 7 than below. This is likely due in part to the
deprotonation of His-18, but the free N-terminus could also
contribute (39,47). Our H18Q-hIAPP mutant allows us to
probe the role of the protonation state of the N-terminus
in a background where no other groups titrate with a similar
pKa. Amyloid formation by the mutant is approximately
fourfold faster at pH 7.5 relative to the rate at pH 5.0
(Fig. 6, Fig. S2). The data highlight the contribution of the
N-terminal charge state to amyloid formation and reveals
that the pKa of the free N-terminus is below 7.5. All models
of IAPP amyloid fibril postulate that the N-terminus is flex-
ible, thus the strong dependence of the rate of amyloid for-
mation on its charge state is striking.CONCLUSIONS
The analysis presented here clearly shows that interactions
involving His-18 and the C-terminus Tyr are not essential
for amyloid formation and, furthermore, show that disrupt-
ing this potential interaction in both backgrounds enhances
the rate of amyloid formation. Previous work, using recom-
binant IAPP with a free C-terminus, provided good evi-
dence, via NMR, for interactions between His-18 and the
C-terminus at pH 5.5 (18). This led to a model for formationFIGURE 6 The pH dependence of amyloid formation by H18Q-hIAPP
shows that the charge state of the N-terminus plays an important role in
amyloid formation. Values of t50 are plotted versus pH. Experiments
were conducted at 25C in 20 mM Tris. The error bars were derived by con-
ducting 3 to 4 independent measurements for each pH. The pH was adjusted
by addition of small amounts of HCl. The maximum added Cl, beyond
that present in the Tris buffer, due to the addition of HCl was 5 mM.of a head-to-tail dimer. Such interactions are expected to be
stronger in the IAPP variant with a free C-terminus at low
pH because the negatively charged carboxylate will make
stronger interactions with His-18, which will be positively
charged at pH 5.5. The data presented here show that if
such interactions are formed in the physiologically relevant
amidated form at physiological pH they do not promote
amyloid formation, but rather hinder it.
Does this mean that the C-terminus of IAPP does not
interact with the side chain of His-18? Not necessarily.
The observation of nonadditive effects between the C-termi-
nus and His-18 is consistent with formation of an inter-
action, although the effects are small. However, this does
not imply that head-to-tail dimers are formed; they may
be, but the fact that replacement of His-18 accelerates amy-
loid formation is broadly consistent with other models of
early intermediates. The helical intermediate model predicts
that the key contacts are made in the region of residues 8 to
18 and replacement of His might improve packing in this
region (21–23). The b-hairpin model involves two intra-
molecular b-hairpins packing together via strand-strand
interactions in the region of residues 11 to 18 and residues
23 to 32 (24). Again, replacement of His-18 could modify
these interactions and might reduce unfavorable interactions
between two polar side chains.
Replacement of the neutral amidated C-terminus with a
negatively charged free carboxylate significantly decreased
the rate of amyloid formation, consistent with previous
studies (39), even though the change decreases the net
charge on the polypeptide, showing that the rate of aggrega-
tion does not correlate with the net charge of the peptide
although electrostatic interactions and peptide ion inter-
actions are important in IAPP aggregation (36). There is a
parallel with the solubility of globular proteins; to a rough
first approximation, proteins are the least soluble when the
pH equals the protein pI, but there are numerous examples
where proteins are actually less soluble when pH does not
equal the pI.
The fact that hIAPP variants with a free C-terminus
are significantly less amyloidogenic argues that hIAPP
is not under strong evolutionary pressure to minimize
amyloidogenicity. The advantages of a modified C-termi-
nus, enhanced resistance to proteases and possibly higher
activity clearly outweigh the deleterious effects of in-
creased in vitro amyloidogenicity. The likely explanations
are that, until very recently, type 2 diabetes and islet amy-
loid did not significantly affect the young, thus prevention
of islet amyloid was not under strong evolutionary pres-
sure. A second, but not exclusive, possibly is that in vitro
amyloidogenicity does not directly correlate with in vivo
amyloidogenicity. The latter point may be relevant for
hIAPP because hIAPP normally does not form amyloid
in vivo even though it is stored in the secretary granule
at concentrations that lead to rapid amyloid formation
in vitro.Biophysical Journal 106(7) 1520–1527
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